DK1694271T3 - FSH-glykosyleringsmutant - Google Patents

FSH-glykosyleringsmutant

Info

Publication number
DK1694271T3
DK1694271T3 DK04783331.4T DK04783331T DK1694271T3 DK 1694271 T3 DK1694271 T3 DK 1694271T3 DK 04783331 T DK04783331 T DK 04783331T DK 1694271 T3 DK1694271 T3 DK 1694271T3
Authority
DK
Denmark
Prior art keywords
fsh
glykosyleringsmutant
mutant
lifes
permits
Prior art date
Application number
DK04783331.4T
Other languages
English (en)
Inventor
Louise M Garone
Stephen J Arkinstall
William H Brondyk
Robert K Campbell
Xuliang Jiang
Sean D Mckenna
Mark Tepper
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Application granted granted Critical
Publication of DK1694271T3 publication Critical patent/DK1694271T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK04783331.4T 2003-09-02 2004-09-02 FSH-glykosyleringsmutant DK1694271T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49980203P 2003-09-02 2003-09-02
PCT/US2004/029042 WO2005020934A2 (en) 2003-09-02 2004-09-02 Fsh glycosylation mutant

Publications (1)

Publication Number Publication Date
DK1694271T3 true DK1694271T3 (da) 2011-09-12

Family

ID=34272871

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04783331.4T DK1694271T3 (da) 2003-09-02 2004-09-02 FSH-glykosyleringsmutant

Country Status (23)

Country Link
US (1) US7700112B2 (da)
EP (1) EP1694271B1 (da)
JP (1) JP4653090B2 (da)
KR (1) KR101099809B1 (da)
CN (1) CN1984926B (da)
AT (1) ATE511829T1 (da)
AU (1) AU2004268683B2 (da)
BR (1) BRPI0413206A (da)
CA (1) CA2535522A1 (da)
CY (1) CY1112439T1 (da)
DK (1) DK1694271T3 (da)
EA (1) EA012175B1 (da)
ES (1) ES2367784T3 (da)
HR (1) HRP20110430T1 (da)
IL (1) IL174037A0 (da)
MX (1) MXPA06002119A (da)
NO (1) NO20061446L (da)
PL (1) PL1694271T3 (da)
PT (1) PT1694271E (da)
SI (1) SI1694271T1 (da)
UA (1) UA88879C2 (da)
WO (1) WO2005020934A2 (da)
ZA (1) ZA200601803B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG155183A1 (en) 2005-08-26 2009-09-30 Ares Trading Sa Process for the preparation of glycosylated interferon beta
US8604175B2 (en) 2005-12-09 2013-12-10 Ares Trading S.A. Method for purifying FSH or a FSH mutant
WO2008010840A2 (en) * 2005-12-22 2008-01-24 Laboratoires Serono S.A. Fsh mutants
DK1981908T3 (da) * 2006-01-17 2010-12-13 Merck Serono Sa Ny FSH-glykosyleringsvariant D3N
EP2479571A3 (en) * 2007-03-26 2012-09-26 Novartis AG Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
AR081755A1 (es) 2010-04-02 2012-10-17 Hanmi Holdings Co Ltd Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo
CN108676096B (zh) * 2018-05-22 2022-03-29 北京伟杰信生物科技有限公司 重组猪fsh-ctp融合蛋白及其制备方法与应用
CA3160345A1 (en) * 2019-11-06 2021-05-14 The Regents Of The University Of Colorado, A Body Corporate Modified follicle-stimulating hormone and methods of using the same
CN114213523B (zh) * 2021-11-15 2024-07-09 广州源博医药科技有限公司 一种用于重组蛋白的高糖基化修饰序列及其重组猪促卵泡激素和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923805A (en) 1983-11-02 1990-05-08 Integrated Genetics, Inc. Fsh
US5639639A (en) 1983-11-02 1997-06-17 Genzyme Corporation Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
US4840896A (en) 1983-11-02 1989-06-20 Integrated Genetics, Inc. Heteropolymeric protein
US5156957A (en) 1983-11-02 1992-10-20 Genzyme Corporation Follicle stimulating hormone
US4845077A (en) 1984-04-03 1989-07-04 Serono Laboratories, Inc. Method of inducing ovulation
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
JP3045539B2 (ja) 1989-02-21 2000-05-29 ワシントン ユニバーシティ 改変型生殖ホルモン
US5338835A (en) 1989-02-21 1994-08-16 Washington University CTP-extended form of FSH
US5508261A (en) 1991-06-18 1996-04-16 University Of Medicine & Dentistry Of New Jersey Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same
US6407205B1 (en) 1997-06-04 2002-06-18 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College FSH-releasing peptides
EP0994718B1 (en) * 1997-06-20 2005-08-17 Akzo Nobel N.V. Gonadotropin releasing hormone antagonist
PT1102763E (pt) 1998-08-07 2005-01-31 Applied Research Systems Mimeticos fsh para o tratamento da infertilidade
CZ302835B6 (cs) 2000-01-27 2011-11-30 Laboratoires Serono Sa Farmaceutický prostredek
US20020127652A1 (en) * 2000-02-11 2002-09-12 Schambye Hans Thalsgard Follicle stimulating hormones
WO2001058493A1 (en) * 2000-02-11 2001-08-16 Maxygen Aps Conjugates of follicle stimulating hormones
CA2469724A1 (en) 2001-10-22 2004-06-17 Applied Research Systems Ars Holding N.V. Mutant glycoproteins

Also Published As

Publication number Publication date
HRP20110430T1 (hr) 2011-07-31
NO20061446L (no) 2006-03-30
KR101099809B1 (ko) 2011-12-27
ZA200601803B (en) 2007-05-30
UA88879C2 (en) 2009-12-10
AU2004268683B2 (en) 2010-06-24
EA012175B1 (ru) 2009-08-28
EA200600526A1 (ru) 2007-04-27
BRPI0413206A (pt) 2006-10-03
PT1694271E (pt) 2011-07-07
IL174037A0 (en) 2006-08-01
SI1694271T1 (sl) 2011-08-31
WO2005020934A2 (en) 2005-03-10
JP4653090B2 (ja) 2011-03-16
CY1112439T1 (el) 2015-12-09
WO2005020934A3 (en) 2007-02-15
PL1694271T3 (pl) 2011-11-30
CA2535522A1 (en) 2005-03-10
ES2367784T3 (es) 2011-11-08
CN1984926B (zh) 2012-04-11
HK1101315A1 (en) 2007-10-12
EP1694271A2 (en) 2006-08-30
EP1694271B1 (en) 2011-06-08
AU2004268683A1 (en) 2005-03-10
CN1984926A (zh) 2007-06-20
MXPA06002119A (es) 2006-05-31
KR20070029620A (ko) 2007-03-14
US7700112B2 (en) 2010-04-20
AU2004268683A2 (en) 2005-03-10
ATE511829T1 (de) 2011-06-15
US20050100989A1 (en) 2005-05-12
JP2007508245A (ja) 2007-04-05

Similar Documents

Publication Publication Date Title
CY1112439T1 (el) Μεταλλαγμα fsh-γλυκοζυλιωσης
AU2003272536A8 (en) Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin
DE60115842D1 (de) Ventilanordnung
ATE299675T1 (de) Einfach an jeden zahnarztstuhl und/oder operationstisch anpassbare armstütze
IL172396A0 (en) Replikin peptides and uses thereof
HUP9900681A2 (hu) TH1/TH2-citokinexpresszió modulálása Ribavirinnel és Ribavirin-analógokkal, aktivált T-limfocitákban
EP1536834A4 (en) DESIGN OF CHEMOKINE ANALOGS FOR THE TREATMENT OF HUMAN DISEASES
MXPA05001885A (es) El uso de una combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica.
DE60115432D1 (de) Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
WO2007084441A3 (en) Novel fsh glycosylation variant d3n
ITTO20020684A1 (it) Nuovo uso dell'angelicina e di suoi analoghi strutturali.
ES2094757T3 (es) Un factor megacariocitopoyetico.
MX2008008322A (es) Mutantes de fsh.
AU2003281257A8 (en) A novel use of rapamycin and structural analogues thereof
WO2004050679A3 (en) Mutant glycoproteins
AU2002364889A8 (en) Methods for diagnosis and treatment of diseases associated with altered expression of nrf2
ATE95995T1 (de) Ergonomisches kopfkissen, insbesondere zur verhuetung und/oder behandlung von nackenbeschwerden.
BR8000814U (pt) Instrumento de massagem à vácuo
GR990100106A (el) Οργανο παθητικης κινησιοθεραπειας σε ορθια θεση για ατομα με αναπηρια στα κατω ακρα
SE9704451D0 (sv) New method and compositions for the treatment of autoimmune diseases
TW200509922A (en) Methods of therapeutic treatment using amounts of retinoid components
TW519919U (en) Structure of health care chair capable of performing therapeutic ch'I-gong with biological spectrum
BR8102461U (pt) Mouse fìsico estimulador
CA102676S (en) Cot